ORIGINAL RESEARCH article

Front. Immunol.

Sec. Mucosal Immunity

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1551311

This article is part of the Research TopicMolecular Mechanisms for Unconventional T Cell-Mediated Inflammatory Skin and Oral Mucosal DiseasesView all articles

Variable innate lymphoid cells predominancy in oral lichen planus latently led to diverse clinical outcomes: a proof-of-concept study

Provisionally accepted
Xi Ye  LiXi Ye Li1,2Lei  PanLei Pan3Yiwen  DengYiwen Deng1,2Jun-jun  ChenJun-jun Chen1,2Zhen  TianZhen Tian2,4Guo-yao  TangGuo-yao Tang5Shu-yun  GeShu-yun Ge1,2*Yu-Feng  WangYu-Feng Wang1,2*
  • 1Department of Oral Medicine, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
  • 2Shanghai Key Laboratory of Stomatology, Shanghai Jiao Tong University, Shanghai, Shanghai Municipality, China
  • 3Second Dental Clinic, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
  • 4Department of Pathology, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
  • 5Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai Municipality, China

The final, formatted version of the article will be published soon.

To search for a new classification scheme for oral lichen planus (OLP) and oral lichenoid lesions (OLL) based on innate lymphoid cells (ILCs) , and evaluate the clinical significance of this classification for diagnosis and treatment.study is based on a clinical cohort and applies flow cytometry to prospectively analyze the ILC subgroups and proportions in OLP and OLL lesions; Using SPSS 26.0 software, attempt cluster analysis to classify diseases at the cellular level based on the phenotype and quantity of ILCs cells; Analyze the correlation between the new classification of diseases and clinical risk factors based on the patient's clinical background information and classification results; And evaluate the differences in therapeutic effects among patients in different groups in corresponding clinical cohorts.In the OLP and OLL groups, the ILC compartment consisted mainly of ILC1 (75.02 ±27.55%, and 72.99±25.23%) , ILC2 (1.49±4.12%, and 1.72±3.18%) and ILC3 (16.52±19.47%, and 18.77±18.12%) were also observed. By using k-means clustering and two-step clustering , patients could be clustered into 3 groups that did not respond equally to the same treatment. Under k-means clustering, there was a statistically significant difference in REU scores between the ILC1 advantage group and the OLL subgroup before and after treatment (P=0.02), which was not found under two-step clustering. This indicated that k-means clustering may have more value for the clinical application of OLL. In the ILC1 absolutely advantage group, using HCQ+TGP for one month could effectively treat the patients no matter using k-means clustering or two-step clustering (P≤0.001), while the other groups did not.This study provides a preliminary OLP and OLL classification method based on ILC subgroups, which can guide the cytological classification of diseases to a certain extent. Further clinical application value needs to be verified by subsequent cohort studies.

Keywords: innate lymphoid cells, Oral lichen planus, Oral lichenoid lesions, Cluster analysis, cohort study

Received: 25 Dec 2024; Accepted: 07 Apr 2025.

Copyright: © 2025 Li, Pan, Deng, Chen, Tian, Tang, Ge and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Shu-yun Ge, Department of Oral Medicine, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200011, China
Yu-Feng Wang, Department of Oral Medicine, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200011, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.